Literatura científica selecionada sobre o tema "Direct cardiac reprogramming"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Direct cardiac reprogramming".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Direct cardiac reprogramming"
Qian, Li, e Deepak Srivastava. "Direct Cardiac Reprogramming". Circulation Research 113, n.º 7 (13 de setembro de 2013): 915–21. http://dx.doi.org/10.1161/circresaha.112.300625.
Texto completo da fonteSadahiro, Taketaro, Shinya Yamanaka e Masaki Ieda. "Direct Cardiac Reprogramming". Circulation Research 116, n.º 8 (10 de abril de 2015): 1378–91. http://dx.doi.org/10.1161/circresaha.116.305374.
Texto completo da fonteBruneau, Benoit G. "Direct Reprogramming for Cardiac Regeneration". Circulation Research 110, n.º 11 (25 de maio de 2012): 1392–94. http://dx.doi.org/10.1161/circresaha.112.270637.
Texto completo da fonteChen, Olivia, e Li Qian. "Direct Cardiac Reprogramming: Advances in Cardiac Regeneration". BioMed Research International 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/580406.
Texto completo da fonteKim, Junyeop, Yujung Chang, Yerim Hwang, Sumin Kim, Yu-Kyoung Oh e Jongpil Kim. "Graphene Nanosheets Mediate Efficient Direct Reprogramming into Induced Cardiomyocytes". Journal of Biomedical Nanotechnology 18, n.º 9 (1 de setembro de 2022): 2171–82. http://dx.doi.org/10.1166/jbn.2022.3416.
Texto completo da fonteZhang, Zhentao, Jesse Villalpando, Wenhui Zhang e Young-Jae Nam. "Chamber-Specific Protein Expression during Direct Cardiac Reprogramming". Cells 10, n.º 6 (16 de junho de 2021): 1513. http://dx.doi.org/10.3390/cells10061513.
Texto completo da fonteSadahiro, Taketaro. "Direct Cardiac Reprogramming ― Converting Cardiac Fibroblasts to Cardiomyocytes ―". Circulation Reports 1, n.º 12 (10 de dezembro de 2019): 564–67. http://dx.doi.org/10.1253/circrep.cr-19-0104.
Texto completo da fonteIeda, Masaki. "Direct cardiac reprogramming by defined factors". Inflammation and Regeneration 33, n.º 4 (2013): 190–96. http://dx.doi.org/10.2492/inflammregen.33.190.
Texto completo da fonteEngel, James L., e Reza Ardehali. "Direct Cardiac Reprogramming: Progress and Promise". Stem Cells International 2018 (2018): 1–10. http://dx.doi.org/10.1155/2018/1435746.
Texto completo da fonteKurotsu, Shota, Takeshi Suzuki e Masaki Ieda. "Mechanical stress regulates cardiac direct reprogramming". Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (2018): OR15–1. http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_or15-1.
Texto completo da fonteTeses / dissertações sobre o assunto "Direct cardiac reprogramming"
Bachamanda, Somesh Dipthi [Verfasser]. "Induced cardiomyocyte precursor cells obtained by direct reprogramming of cardiac fibroblasts / Dipthi Bachamanda Somesh". Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2020. http://d-nb.info/1223925676/34.
Texto completo da fonteElkhoury, Kamil. "Nanofunctionalization and biofabrication of natural hydrogels for tissue engineering applications". Electronic Thesis or Diss., Université de Lorraine, 2021. http://www.theses.fr/2021LORR0020.
Texto completo da fonteThe main objective of this thesis is to develop a new natural material based on methacrylated gelatin (GelMA) nanofunctionalized by the incorporation of nanoliposomes or soft hybrid exosome-liposome nanoparticles. The physicochemical and biological properties of these hydrogel matrices were characterized in order to evaluate their potential use for tissue engineering applications. GelMA is prepared by the chemical modification of gelatin when methacrylate groups are attached to side groups containing amine functions. In a first part of this work, the influence of the gelatin source (pork or fish) and the degree of methacrylation on the physicochemical and biological properties of hydrogels was studied. In a second part of this work, the GelMA matrix was nanofunctionalized by the incorporation of nanoliposomes, which are soft and natural nanoparticles with remarkable self-assembly properties. These well-established drug delivery systems are formed of lipid bilayers and can transport and release hydrophobic, hydrophilic, and amphiphilic molecules. In this study, naringin, an active molecule that can guide the differentiation process of stem cells to the osteoblastic lineage, was encapsulated in nanoliposomes before their incorporation into the GelMA polymeric matrix in order to develop a system of interest for bone regeneration applications. This nanocomposite material was physicochemically and biologically characterized and the release profile of naringin was investigated. In a third and final part of this work, the GelMA matrix was nanofunctionalized by the incorporation of exosome-liposome soft hybrid nanoparticles. Exosomes, natural nanovesicles secreted by cells, are of increasing interest for targeted drug delivery applications due to the presence of cell specific receptors on their surface. The hybrid GelMA hydrogels were physicochemically and biologically characterized for applications in cardiac reprogramming and was successfully bioprinted and microfabricated. Biofabricated GelMA hydrogels nanofunctionalized with nanoliposomes or hybrid exosome-liposome nanoparticles are promising platforms for the controlled release of bioactive molecules and for tissue engineering applications
Capítulos de livros sobre o assunto "Direct cardiac reprogramming"
Haginiwa, Sho, e Masaki Ieda. "Direct Cardiac Reprogramming". In Cardiac and Vascular Biology, 123–43. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56106-6_6.
Texto completo da fonteLiu, Dingqian, Khawaja Husnain Haider e Changfa Guo. "Bioengineering Technique Progress of Direct Cardiac Reprogramming". In Handbook of Stem Cell Therapy, 1333–65. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2655-6_27.
Texto completo da fonteJayawardena, Tilanthi, Maria Mirotsou e Victor J. Dzau. "Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes Using MicroRNAs". In Methods in Molecular Biology, 263–72. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0512-6_18.
Texto completo da fontePaoletti, Camilla, Carla Divieto e Valeria Chiono. "Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo". In Methods in Molecular Biology, 31–40. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2707-5_3.
Texto completo da fonteMa, Hong, Li Wang, Jiandong Liu e Li Qian. "Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction". In Methods in Molecular Biology, 69–88. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-6588-5_5.
Texto completo da fontePaoletti, Camilla, Carla Divieto e Valeria Chiono. "Correction to: Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo". In Methods in Molecular Biology, C1. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-2707-5_27.
Texto completo da fonteJain, Pooja, Nazia Hassan, Uzma Farooq e Zeenat Iqbal. "Nanotechnology-Based Direct Cardiac Reprogramming for Cardiac Regeneration". In Nanomedicinal Approaches Towards Cardiovascular Disease, 106–24. BENTHAM SCIENCE PUBLISHERS, 2021. http://dx.doi.org/10.2174/9789814998215121010015.
Texto completo da fonteHaridhasapavalan, Krishna Kumar, Atreyee Borthakur e Rajkumar P. Thummer. "Direct Cardiac Reprogramming: Current Status and Future Prospects". In Advances in Experimental Medicine and Biology. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/5584_2022_760.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Direct cardiac reprogramming"
Klose, K., M. Gossen e C. Stamm. "Direct Genetic and/or Pharmacologic Reprogramming for Creation of Cardiomyocytes: Is It Real?" In 48th Annual Meeting German Society for Thoracic, Cardiac, and Vascular Surgery. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1678823.
Texto completo da fonte